NCT06535789 - Inhaled Insulin vs Rapid-acting Injections for Post-meal Glucose Control in Women With Gestational Diabetes | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

May 31, 2025

Primary Completion Date

July 31, 2025

Study Completion Date

July 31, 2025

Conditions

Diabetes, GestationalPregnancy ComplicationsGlucose Metabolism DisordersGlucose Intolerance During Pregnancy

Interventions

DRUG

Inhaled Technosphere Insulin

Patients will receive TI (Afrezza) to be compared to RAA following a breakfast meal

Trial Locations (5)

RECRUITING

Icahn School of Medicine at Mount Sinai, New York

RECRUITING

University of Pennsylvania, Philadelphia

RECRUITING

University of Colorado Anschutz Medical Campus, Aurora

RECRUITING

Sansum Diabetes Research Institute, Santa Barbara

RECRUITING

Oregon Health and Science University, Portland